Exact Mass: 988.3899674
Exact Mass Matches: 988.3899674
Found 8 metabolites which its exact mass value is equals to given mass value 988.3899674,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
C48H60O22_beta-D-Glucopyranose, 1-O-[(2E,4E,6E,8E,10E,12E,14E)-16-[[(1R,2R,3R,5S)-5-carboxy-2-[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-3,5-dihydroxycyclohexyl]oxy]-2,6,11,15-tetramethyl-1,16-dioxo-2,4,6,8,10,12,14-hexadecaheptaen-1-yl]-6-O-beta-D-glucopyranosyl
NCGC00384868-01_C48H60O22_beta-D-Glucopyranose, 1-O-[(2E,4E,6E,8E,10E,12E,14E)-16-[[(1R,2R,3R,5S)-5-carboxy-2-[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-3,5-dihydroxycyclohexyl]oxy]-2,6,11,15-tetramethyl-1,16-dioxo-2,4,6,8,10,12,14-hexadecaheptaen-1-yl]-6-O-beta-D-glucopyranosyl-
4-Methoxyphenyl 4-O-(2,4,6-Tri-O-benzyl-beta-D-galactopyranosyl)-2,3,6-tri-O-benzyl-beta-D-glucopyranoside
4-Methoxyphenyl 4-O-(2,4,6-Tri-O-benzyl-beta-D-galactopyranosyl)-2,3,6-tri-O-benzyl-beta-D-glucopyranoside
4-Methoxyphenyl 4-O-(2,3,6-Tri-O-benzyl-beta-D-galactopyranosyl)-2,3,6-tri-O-benzyl-beta-D-glucopyranoside
4-Methoxyphenyl 4-O-(2,3,6-Tri-O-benzyl-beta-D-galactopyranosyl)-2,3,6-tri-O-benzyl-beta-D-glucopyranoside
O-[2-Azido-2-deoxy-4,6-O-[(S)-phenylmethylene]-3-O-(2,3,4,6-tetra-O-acetyl-beta-D-galactopyranosyl)-alpha-D-galactopyranosyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-serine 1,1-dimethylethyl ester
O-[2-Azido-2-deoxy-4,6-O-[(S)-phenylmethylene]-3-O-(2,3,4,6-tetra-O-acetyl-beta-D-galactopyranosyl)-alpha-D-galactopyranosyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-serine 1,1-dimethylethyl ester
3-methoxy-17-methyl-4,5alpha-epoxymorphinan-6-one (2R,3R)-2,3-dihydroxybutanedioic acid pentahydrate
3-methoxy-17-methyl-4,5alpha-epoxymorphinan-6-one (2R,3R)-2,3-dihydroxybutanedioic acid pentahydrate
Certepetide
Certepetide
C37H60N14O14S2 (988.3854660000001)
Certepetide (CEND-1) is a bifunctional cyclic peptide (a.k.a. iRGD). Certepetide is a tumor-penetrating enhancer via RGD motif interaction with alphav-integrins and via activating NRP-1, and transforms the solid tumor microenvironment into a temporary agent conduit. Certepetide accumulates in tumors, and is used in the research of pancreatic cancer and other solid tumors[1][2][3].
(2r,3r)-3-{[(2s)-2-amino-1-hydroxy-6-({hydroxy[(1s)-8-hydroxy-5-{[1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-9-oxo-1h,2h,3h,4h-pyrimido[1,2-a]quinolin-1-yl]methylidene}amino)hexylidene]amino}-2-hydroxy-3-{[(1s)-1-{[(1r,2r)-2-hydroxy-1-{[(1s)-1-{[(3r)-1-hydroxy-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}ethyl]-c-hydroxycarbonimidoyl}propyl]-c-hydroxycarbonimidoyl}ethyl]-c-hydroxycarbonimidoyl}propanoic acid
(2r,3r)-3-{[(2s)-2-amino-1-hydroxy-6-({hydroxy[(1s)-8-hydroxy-5-{[1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-9-oxo-1h,2h,3h,4h-pyrimido[1,2-a]quinolin-1-yl]methylidene}amino)hexylidene]amino}-2-hydroxy-3-{[(1s)-1-{[(1r,2r)-2-hydroxy-1-{[(1s)-1-{[(3r)-1-hydroxy-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}ethyl]-c-hydroxycarbonimidoyl}propyl]-c-hydroxycarbonimidoyl}ethyl]-c-hydroxycarbonimidoyl}propanoic acid